清肺排毒汤治疗新型冠状病毒肺炎的临床疗效观察

目的:分析清肺排毒汤治疗新型冠状病毒肺炎的临床疗效。方法:对四川省纳入的98例新型冠状病毒肺炎确诊患者用清肺排毒汤进行3 d为一疗程的治疗,3个疗程后,比较服药前和服药后患者实验室检测指标和中医证候的变化,根据实验室指标及症状的无、轻、中、重程度,给予相应的评分,探讨清肺排毒汤治疗新型冠状病毒肺炎的临床疗效。结果:服用清肺排毒汤3 d后,患者淋巴细胞百分率、天门冬氨酸氨基转移酶和丙氨酸氨基转移酶、D-二聚体恢复正常(P <0. 01),所有患者实验室检查指标正常例数均在70%以上;服用清肺排毒汤6 d后,C反应蛋白和血沉恢复正常(P <0. 01),所有患者实验室检查指标正常例数均在80%以上;服用清肺排毒汤9 d后,所有患者实验室检查指标正常例数均在90%以上。并且CT影像在治疗6 d后好转79人,好转率80%以上。从治疗中医证候积分看,治疗3 d后总有效率为84. 22%,其中痊愈率为21. 14%,显效率为29. 09%,有效率为33. 99%;治疗6 d后总有效率90. 15%,其中痊愈率31. 34%,显效率为30. 15%,有效率为28. 66%;治疗9 d后总有效率92. 09%,其中痊愈率41. 13%,显效率为26. 92%,有效率为24. 04%。结论:清肺排毒汤对于治疗新型冠状病毒肺炎有很好的临床疗效,能显著改善患者的实验室检测异常指标和临床症状,可减少患者不良反应情况,有效提高治疗效果,值得临床推广使用。

Clinical Observation of Qingfeipaidu Decoction in the Treatment of COVID-19

Objective: To analyze the therapeutic effect of Qingfeipaidu decoction on the treatment of new coronavirus pneumonia in clinical practice. Methods: 98 cases of newly diagnosed coronavirus pneumonia patients in Sichuan province were treated with Qingfeipaidu decoction for3 consecutive courses,each course lasting 3 days. After 3 courses,the changes of laboratory indexes and TCM syndromes of patients before and after treatment were compared. Scores were recorded according to the severity of symptoms( no symptom,mild,general and severe) to investigate the therapeutic effect of Qingfeipaidu decoction on the treatment of new coronavirus pneumonia. Result: After 3 days of the treatment,the levels of lymphocyte percentage,AST,ALT and D-dimer were recovered to normal( P < 0. 01),while laboratory indexes became normal over 70% of the patients. After 6 days of the treatment,C-reactive protein and erythrocyte sedimentation rate( ESR) was recovered to normal( P < 0. 01),while laboratory indexes became normal over 80% of the patients. After 9 days of the treatment,laboratory indexes became normal over 90% of the patients. CT diagnose result showed 79 patients were improved after 6 days treatment,the recovery rate was more than 80%. According to the TCM syndrome scores,after one course of treatment( 3 days),the total effective rate was 84. 22%,among which the recovery rate was 21. 14%,the significant efficiency was29. 09%,and the effective rate was 33. 99%. After two courses of treatment( 6 days),the total effective rate was 90. 15%,among which the recovery rate was 31. 34%,the significant efficiency was 30. 15%,and the effective rate was 28. 66%. After three courses of treatment( 9 days),the total effective rate was 92. 09%,among which the recovery rate was 41. 13%,the significant efficiency was 26. 92%,and the effective rate was 24. 04%. Conclusion: Qingfeipaidu decoction has a good therapeutic effect on the treatment of new coronavirus pneumonia in clinical practice. It significantly improves the abnormal laboratory indexes and clinical symptoms of patients,reduces the adverse reactions of patients,and improves the therapeutic effect. It’s worthy of clinical promotion.